Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ACT 178882

Next Previous
X
Search
Drug Profile

ACT 178882

Alternative Names: ACT-178882; MK-1597

Latest Information Update: 01 Apr 2016

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Actelion Pharmaceuticals; Merck & Co
  • Developer Actelion Pharmaceuticals
  • Class Amides; Antihypertensives; Piperidines; Pyrimidines
  • Mechanism of Action Renin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Hypertension

Most Recent Events

  • 05 Feb 2013 Phase-I clinical trials in Hypertension in Switzerland (PO)
  • 05 Feb 2013 Drug interactions & adverse events data from a phase I trial in Healthy volunteers released by Actelion Pharmaceuticals
  • 19 Jul 2012 ACT 178882 is available for licensing as of 19 Jul 2012. http://www.actelion.com/en/index.page

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top